PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.

Abstract

BACKGROUND & AIMS:

We have previously reported that Shp2, a tyrosine phosphatase previously known as a pro-leukemogenic molecule, suppresses the initiation of hepatocellular carcinoma (HCC). However, the role of Shp2 in HCC progression remains obscure.

METHODS:

Shp2 expression was determined in human HCC using real-time PCR, immunoblotting and immunohistochemistry. Clinical significance of Shp2 expression was analyzed in 301 HCC tissues with clinico-pathological characteristics and follow-up information. Short hairpin RNA was utilized to investigate the function of Shp2 in hepatoma cell behavior. Role of Shp2 in HCC progression was monitored through nude mice xenograft assay. Kinase activity assay and co-immunoprecipitation were used for mechanism analysis.

RESULTS:

Elevated expression of Shp2 was detected in 65.9% (394/598) of human HCCs, and its levels were even higher in metastasized foci. Overexpression of Shp2 correlated well with the malignant clinico-pathological characteristics of HCC and predicted the poor prognosis of patients. Interference of Shp2 expression suppressed the proliferation of hepatoma cells in vitro and inhibited the growth of HCC xenografts in vivo. Down-regulation of Shp2 attenuated the adhesion and migration of hepatoma cells and diminished metastasized HCC formation in mice. Our data demonstrated that Shp2 promotes HCC growth and metastasis by coordinately activating Ras/Raf/Erk pathway and PI3-K/Akt/mTOR cascade. Moreover, down-regulation of Shp2 enhanced the sensitivity of hepatoma cells upon sorafenib treatment, and patients with low Shp2 expression exhibited superior prognosis to sorafenib.

CONCLUSIONS:

Shp2 promotes the progression of HCC and may serve as a prognostic biomarker for patients.

• Authors: Tao Han, Dai-Min Xiang, Wen Sun, Na Liu, Huan-Lin Sun, Wen Wen, Wei-Feng Shen, Ruo-Yu Wang, Cheng Chen, Xue Wang, Zhuo Cheng, Heng-Yu Li, Meng-Chao Wu, Wen-Ming Cong, Gen-Sheng Feng, Jin Ding, Hong-Yang Wang
• Journal: Journal of hepatology (J Hepatol) Vol. 63 Issue 3 Pg. 651-60 (Sep 2015) ISSN: 1600-0641 [Electronic] Netherlands
• PMID: 25865556 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Chemical References

• Phenylurea Compounds
• Niacinamide
• Sorafenib
• Phosphatidylinositol 3-Kinases
• raf Kinases
• PTPN11 protein, human
• Protein Tyrosine Phosphatase, Non-Receptor Type 11

Topics

• Animals
• Carcinoma, Hepatocellular (etiology, mortality)
• Cell Line, Tumor
• Cell Proliferation
• Disease Progression
• Humans
• Liver Neoplasms (etiology, mortality)
• MAP Kinase Signaling System
• Mice
• Niacinamide (analogs & derivatives, pharmacology)
• Phenylurea Compounds (pharmacology)
• Phosphatidylinositol 3-Kinases (physiology)
• Prognosis
• Protein Tyrosine Phosphatase, Non-Receptor Type 11 (physiology)
• Sorafenib
• raf Kinases (physiology)